| J3111 | Injection, romosozumab-aqqg, 1 mg | 17,430 | $10 | $139.4K |
| J0897 | Injection, denosumab, 1 mg | 2,760 | $20 | $46.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 280 | $130 | $34.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 150 | $80 | $12.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $160 | $8.5K |
| 76536 | The provider performs real–time ultrasound examination of the soft tissues of the head and neck and records and saves the images for later review. | 60 | $80 | $4.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 60 | $60 | $3.5K |
| 10005 | Under ultrasound guidance, the provider performs a fine needle aspiration (FNA), a diagnostic procedure that involves collecting a specimen from tissue, a cyst, or mass using a specialized needle and… | 10 | $100 | $1.4K |
| 95251 | A provider analyzes and interprets data from a patient’s continuous glucose monitor (CGM) and writes a report based on interpretation. This code represents the professional component of the service… | 50 | $30 | $1.2K |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary… | 50 | $20 | $1.1K |